Editor’s choice: Human Anthrax as a Re-Emerging Disease

Recent Patents on Anti-Infective Drug Discovery

Author(s): Mehmet Doganay and Hayati Demiraslan.

Abstract: Anthrax is primarily a disease of herbivores and the etiological agent is B. anthracis which is a gram-positive, aerobic, spore-forming, and rod shaped bacterium. Bacillus anthracis spores are highly resistant to heat, pressure, ultraviolet and ionizing radiation, chemical agents and disinfectants. For these reasons, B. anthracis spores are an attractive choice as biological agents for the use of bioweapon and/or bioterrorism. Soil is the main reservoir for the infectious agent. The disease most commonly affects wild and domestic mammals. Human are secondarily infected by contact with infected animals and contaminated animal products or directly expose to B. anthracis spores. Anthrax occurs worldwide. This infection is still endemic or hyperendemic in both animals and humans in some part of areas of the world; particularly in Middle East, West Africa, Central Asia, some part of India, South America. However, some countries are claiming free of anthrax, and anthrax has become a re-emerging disease in western countries with the intentional outbreak. Currently, anthrax is classified according to its setting as (1) naturally occurring anthrax, (2) bioterrorism-related anthrax. Vast majority of human anthrax are occurring as naturally occurring anthrax in the world. It is also a threaten disease for western countries. The aim of this paper is to review the relevant patents, short historical perspective, microbiological and epidemiological features, clinical presentations and treatment.

More here: http://benthamscience.com/journals/recent-patents-on-anti-infective-drug-discovery/35

 

Free trials of Bentham Journals are active in the following universities:

 

University of Connecticut USA

The University of Connecticut is one of the top public research universities in the nation, with more than 30,000 students pursuing answers to critical questions in labs, lecture halls, and the community. Knowledge exploration throughout the University’s network of campuses is united by a culture of innovation. An unprecedented commitment from the state of Connecticut ensures UConn attracts internationally renowned faculty and the world’s brightest students. A tradition of coaching winning athletes makes UConn a standout in Division l sports and fuels our academic spirit. As a vibrant, progressive leader, UConn fosters a diverse and dynamic culture that meets the challenges of a changing global society.

http://uconn.edu

Otsuka Pharmaceutical Co. Ltd Japan

Otsuka Pharmaceutical was established in Tokushima Prefecture, Japan in 1964. At Otsuka Pharmaceutical, we are committed to a holistic approach to health and well-being of people and are striving to create innovative, thoroughly-original pharmaceutical and nutraceutical products based on our corporate philosophy “Otsuka-people creating new products for better health worldwide”.

http://www.otsuka.co.jp/en/index.php

free trial2
Free Online Trial Request form  
http://bit.ly/1BeXpmZ
Email for further assistance:
marketing@benthamscience.org

Special Thematic Issue: Innovation in Environmental Engineering

^B497B4EAA1CA2125101E5A20DA29123BCB7B07AFF20284ED75^pimgpsh_fullsize_distr

 

Innovation in Environmental Engineering

Aim and scope: To address the latest developments and key topics in the field of innovative methods, processes, devices, analysis, modeling and assessment of effects of environmental pressures on humans and ecosystems. The special issue of the journal seeks to disseminate original research papers on all aspects of the field of environmental engineering and related sciences, including but not limited to the study of ecology, hydrology, agronomy, geology, and engineering sciences.

We aim to bring important work using innovative approaches, techniques and models in environmental engineering to a wider, global audience and therefore seek scientific papers with strong ideas that assist in advancing our understanding of environmental and engineering principles.

Keywords: Energy Management, Wastewater management, Air pollution control, recycling, waste disposal, environmental sustainability, global warming, ozone depletion and public health

Subtopics:

  • Water and waste water treatment
  • Energy efficiency and control
  • Pollution and Public Health
  • Global warming and ozone depletion
  • Other novel resource-based technologies usage

    Tentative Authors: Sanwar A. Sunny, Dr. Kamrun Nahar, and others

2015-10-29_15-46-50

Recently published issues in various journals of Bentham Science

Current Drug Targets, 16 Issue 11
http://bit.ly/1LYCeKh

Current Organic Chemistry, 19 Issue 24
http://bit.ly/1MT4rC3

Letters in Drug Design & Discovery, 12 Issue 10
http://bit.ly/1NAcGG1

Current Vascular Pharmacology, 13 Issue 6
http://bit.ly/1kQQpKP

Current Drug Metabolism, 16 Issue 6
http://bit.ly/209Lm8o

Current Topics in Medicinal Chemistry, 16 Issue 3
http://bit.ly/1RB2Ft0

CNS & Neurological Disorders – Drug Targets, 14 Issue 8
http://bit.ly/1jQLeu6

Current Pharmaceutical Design, 21 Issue 30
http://bit.ly/1GwTzgE

Current Pharmaceutical Design, 21 Issue 29
http://bit.ly/1WihIZQ

MicroRNA, 4 Issue 2
http://bit.ly/1O7dxRv

Anti-Cancer Agents in Medicinal Chemistry, 15 Issue 10
http://bit.ly/1GwUqOr

Current Analytical Chemistry, 12 Issue 1
http://bit.ly/209RNZ4

Letters in Organic Chemistry, 12 Issue 9
http://bit.ly/1SaHAGt

Mini-Reviews in Medicinal Chemistry, 15 Issue 14
http://bit.ly/1KGZKJJ

Current Molecular Medicine, 15 Issue 8
http://bit.ly/1KGZNW7

Recently published 2

World Stroke Day – 29th October 2015

banner-World-Stroke-Day

For latest research on stroke, please visit our journal: Current Cardiology Reviews

Current Cardiology Reviews publishes frontier reviews of high quality on all the latest advances on the practical and clinical approach to the diagnosis and treatment of cardiovascular disease. All relevant areas are covered by the journal including arrhythmia, congestive heart failure, cardiomyopathy, congenital heart disease, drugs, methodology, pacing, and preventive cardiology. The journal is essential reading for all researchers and clinicians in cardiology.

Contributor’s Comments

2015-10-28_14-24-00

This article is from the journal ‘Neuroscience and Biomedical Engineering’

Contributed article: ‘Getting in sync: A new Ready-to-use Biofield Resonance Device (Vita Chip) Reduces Chronic Pain and Increases Wellbeing’

 

Free trials of Bentham Journals are active in the following universities:

 

Sun Yat-sen University – China

Sun Yat-sen University, originally known as Guangdong University, was founded in 1924 by Dr. Sun Yat-sen (also called Sun Zhongshan), a great democratic revolutionary leader of the 20th century. The University is located in Guangdong Province, an area neighboring Hong Kong and Macao, which is at the forefront of China’s reform and opening up.

Being one of the leading universities in the People’s Republic of China, Sun Yat-sen University is a comprehensive multi-disciplinary university, including the humanities, social sciences, natural sciences, technical sciences, medical sciences, pharmacology, and management sciences. 

http://www.sysu.edu.cn/2012/en/index.html


National Autonomous University of Mexico

The National Autonomous University of Mexico has played a leading role in the history and formation of our country. The substantive work of this public, autonomous and lay institution are teaching, research and dissemination of culture.

In the academic world it is recognized as a university of excellence. UNAM responds to the present and looks to the future as the most important cultural project in Mexico.

The UNAM is a space of freedom. In her daily practice respect, tolerance and dialogue. The plurality of ideas and thought is appreciated as a sign of their wealth and never as a weakness factor.

http://eap.ucop.edu/OurPrograms/mexico/Pages/national_autonomous_mexico.aspx

free trial2
Free Online Trial Request form  
http://bit.ly/1BeXpmZ
Email for further assistance:
marketing@benthamscience.org

New Issue ::: Current Vascular Pharmacology

Current Vascular Pharmacology publishes clinical and research-based reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research. Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief).

Following are the articles from the journal Current Vascular Pharmacology, 13 issue 5:

Article: Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists

Author(s): Jie Tang, Mu-Peng Li, Hong-Hao Zhou and Xiao-Ping Chen

 

Article: Glycaemic Control in Cardiac Surgery Patients: a Double-Edged Sword

Author(s):  Lukasz J. Krzych and Maciej T. Wybraniec

 

Article: Is there a Role for Cortisol in the Accumulation of Lipids in the Intima a Crucial Step of Atherogenesis?

Author(s): Panayotis Fantidis, Sanchez Eladio, Tarhini Ibrahim, Pineda Tomas, Corrales Jose Antonio and Gonzalez Jose Ramon

 

Article: Recent Advances in Optimal Adjunctive Antithrombotic Therapy in STEMI Patients Undergoing Primary Angioplasty: An Overview

Author(s): Giuseppe De Luca and Harry Suryapranata

 

Article: Pharmacogenetics and Statin Treatment: Reality or Theory?

Author(s):  Eleni Bousoula, Vana Kolovou, Despoina Perrea and Genovefa Kolovou

 

Article: Diabetes Mellitus in Patients Presenting with Cardiovascular Events: Descriptive Analysis from a Tertiary Heart Hospital Over a 22-year Period

Author(s): Ayman El-Menyar, Hassan Al-Thani, Ahammed Mekkodathil, Shaban Mohammed, Rajvir Singh, Hajar AlBinAli and Jassim Al Suwaidi

 

Article: Coffee: A Selected Overview of Beneficial or Harmful Effects on the Cardiovascular System?

Author(s):  Thomas F. Whayne

 

Article: Incretin-Based Antidiabetic Agents for the Management of Non-Alcoholic Fatty Liver Disease

Author(s): Theodora Nakouti, Apostolos K.A. Karagiannis, Konstantinos Tziomalos and Evangelos Cholongitas

 

Article: Heart Failure Models: Traditional and Novel Therapy

Author(s): Mohamed A. Haidara, Abdullah S. Assiri, Hanaa Z. Yassin, Hania I. Ammar, Milan M. Obradovic and Esma R. Isenovic

 

Article: Tenofovir-Related Nephropathies in HIV-Infected Patients

Author(s): Silvia Lai, Amalia Mariotti, Carlo Lai, Massimo Testorio, Maria Carta, Georgie Innico, Nicla Frassetti, Marco Mangiulli, Annarita D’Angelo and Gaspare E. Russo

 

Article: Not Simply a Matter of Fish Intake

Author(s): Carlos Scherr, Valeria N. Figueiredo, Filipe A. Moura and Andrei C. Sposito

 

Article: MicroRNA-10b Induces Vascular Muscle Cell Proliferation Through Akt Pathway by Targeting TIP30

Author(s): Xin Yu, Zheng Li, Guang Chen and William Ka Kei Wu

 

Article: Relation between the Change in Mean Platelet Volume and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention

Author(s): Young-Youp Koh, Hyung Ho Kim, Dong-Hyun Choi, Young-Min Lee, Young-Jae Ki, Seong-Ho Kang, Geon Park, Joong-Wha Chung, Kyong-Sig Chang and Soon-Pyo Hong

Article: eBook Review: Review of The Bentham e-Book Titled “Thrombosis and Inflammation in Acute Coronary Syndromes” Edited by Ertugrul Ercan and Gulfem Ece

Author(s): Niki Katsiki

 

For details, please visit: http://bit.ly/1Qhe8gC

 

Journal abstracts in Chinese 在中国提供

Current Drug Targets
Volume 16 – Number 10

Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond

Urpo Lamminmaki, Dimitar Nikolov and Juha Himanen.

View Abstract 中文摘要
Purchase Online
View on PubMed
Order Reprints
Order Eprints
Rights and Permissions


 

Targeting the Eph System with Peptides and Peptide Conjugates

Stefan J. Riedl and Elena B Pasquale.

View Abstract 中文摘要
Purchase Online
View on PubMed
Order Reprints
Order Eprints
Rights and Permissions


 Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors

Massimiliano Tognolini and Alessio Lodola.

View Abstract 中文摘要
Purchase Online
View on PubMed
Order Reprints
Order Eprints
Rights and Permissions


-See more: http://benthamscience.com/journals/current-drug-targets/volume/16/issue/10/

Podcast on the article ‘Theories and Treatment of Drug Dependency…’

Watch this podcast here:
https://www.youtube.com/watch?v=SE3pLF7E8ao

To watch other podcasts on articles and eBooks, please visit:
 https://www.youtube.com/channel/UCFzSVHgGkjFW2Q8WV8-gzUw